BACKGROUND: Hypoxia can halt cell cycle progression of several cell types at the G1/S interface. The arrest needs to be overcome by cancer cells. We have previously shown that the hypoxia-inducible cellular oxygen sensor PHD3/EGLN3 enhances hypoxic cell cycle entry at the G1/S boundary. METHODS: We used PHD3 knockdown by siRNA and shRNA in HeLa and 786-0 renal cancer cells. Flow cytometry with cell synchronization was used to study cell growth at different cell cycle phases. Total and phosphospecific antibodies together with cycloheximide chase were used to study p27/CDKN1B expression and fractionations for subcellular protein localization. RESULTS: Here we show that PHD3 enhances cell cycle by decreasing the expression of the CDK inhibitor p27/CDKN1B. PHD3 reduction led to increased p27 expression under hypoxia or VHL mutation. p27 was both required and sufficient for the PHD3 knockdown induced cell cycle block. PHD3 knockdown did not affect p27 transcription and the effect was HIF-independent. In contrast, PHD3 depletion increased the p27 half-life from G0 to S-phase. PHD3 depletion led to an increase in p27 phosphorylation at serine 10 without affecting threonine phosphorylation. Intact serine 10 was required for normal hypoxic and PHD3-mediated degradation of p27. CONCLUSIONS: The data demonstrates that PHD3 can drive cell cycle entry at the G1/S transition through decreasing the half-life of p27 that occurs by attenuating p27S10 phosphorylation.

Department of Medical Biochemistry Faculty of Medicine University of Turku Kiinamyllynkatu 10 20520 Turku Finland

Department of Oncology and Radiotherapy Turku University Hospital Hämeentie 11 20520 Turku Finland

Present address Institute of Biophysics The Academy of Sciences of the Czech Republic Brno Czech Republic

Turku Centre for Biotechnology University of Turku and Åbo Akademi University Tykistökatu 6B 20520 Turku Finland

Zobrazit více v PubMed

Vaupel P. Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis. Oncologist. 2008;13:21–6. doi: 10.1634/theoncologist.13-S3-21. PubMed DOI

Pettersen EO, Lindmo T. Inhibition of cell-cycle progression by acute treatment with various degrees of hypoxia: modifications induced by low concentrations of misonidazole present during hypoxia. Br J Cancer. 1983;48:809–17. doi: 10.1038/bjc.1983.271. PubMed DOI PMC

Ludlow JW, Howell RL, Smith HC. Hypoxic stress induces reversible hypophosphorylation of pRB and reduction in cyclin A abundance independent of cell cycle progression. Oncogene. 1993;8:331–9. PubMed

Krtolica A, Krucher NA, Ludlow JW. Hypoxia-induced pRB hypophosphorylation results from downregulation of CDK and upregulation of PP1 activities. Oncogene. 1998;17:2295–304. doi: 10.1038/sj.onc.1202159. PubMed DOI

Green SL, Freiberg RA, Giaccia AJ. p21(Cip1) and p27(Kip1) regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest. Mol Cell Biol. 2001;21:1196–206. doi: 10.1128/MCB.21.4.1196-1206.2001. PubMed DOI PMC

Gardner LB, Li Q, Park MS, Flanagan WM, Semenza GL, Dang CV. Hypoxia inhibits G1/S transition through regulation of p27 expression. J Biol Chem. 2001;276:7919–26. doi: 10.1074/jbc.M010189200. PubMed DOI

Zygmunt A, Tedesco VC, Udho E, Krucher NA. Hypoxia Stimulates p16 Expression and Association with cdk4. Exp Cell Res. 2002;278:53–60. doi: 10.1006/excr.2002.5564. PubMed DOI

Vervoorts J, Luscher B. Post-translational regulation of the tumor suppressor p27(KIP1) Cell Mol Life Sci. 2008;65:3255–64. doi: 10.1007/s00018-008-8296-7. PubMed DOI PMC

Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 1997;11(11):1464–78. doi: 10.1101/gad.11.11.1464. PubMed DOI

Vlach J, Hennecke S, Amati B. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1. EMBO J. 1997;16:5334–44. doi: 10.1093/emboj/16.17.5334. PubMed DOI PMC

Tsvetkov LM, Yeh K-H, Lee S-J, Sun H, Zhang H. p27Kip1 ubiquitination and degradation is regulated by the SCFSkp2 complex through phosphorylated Thr187 in p27. Curr Biol. 1999;9:661–S662. doi: 10.1016/S0960-9822(99)80290-5. PubMed DOI

Sutterluty H, Chatelain E, Marti A, Wirbelauer C, Senften M, Muller U, Krek W. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol. 1999;1:207–14. doi: 10.1038/12027. PubMed DOI

Carrano AC, Eytan E, Hershko A, Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol. 1999;1:193–9. doi: 10.1038/12013. PubMed DOI

Ishida N, Kitagawa M, Hatakeyama S, Nakayama K-I. Phosphorylation at Serine 10, a Major Phosphorylation Site of p27 Kip1, Increases Its Protein Stability. J Biol Chem. 2000;275:25146–54. doi: 10.1074/jbc.M001144200. PubMed DOI

Rodier G, Montagnoli A, Di Marcotullio L, Coulombe P, Draetta GF, Pagano M, Meloche S. p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J. 2001;20:6672–82. doi: 10.1093/emboj/20.23.6672. PubMed DOI PMC

Ishida N, Hara T, Kamura T, Yoshida M, Nakayama K, Nakayama KI. Phosphorylation of p27 Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J Biol Chem. 2002;277:14355–8. doi: 10.1074/jbc.C100762200. PubMed DOI

Besson A, Gurian-West M, Chen X, Kelly-Spratt KS, Kemp CJ, Roberts JM. A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. Genes Dev. 2006;20:47–64. doi: 10.1101/gad.1384406. PubMed DOI PMC

Kamura T, Hara T, Matsumoto M, Ishida N, Okumura F, Hatakeyama S, Yoshida M, Nakayama K, Nakayama KI. Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase. Nat Cell Biol. 2004;6:1229–35. doi: 10.1038/ncb1194. PubMed DOI

Kotoshiba S, Kamura T, Hara T, Ishida N, Nakayama KI. Molecular dissection of the interaction between p27 and Kip1 ubiquitylation-promoting complex, the ubiquitin ligase that regulates proteolysis of p27 in G1 phase. J Biol Chem. 2005;280:17694–700. doi: 10.1074/jbc.M500866200. PubMed DOI

Kossatz U, Vervoorts J, Nickeleit I, Sundberg HA, Arthur JS, Manns MP, Malek NP. C-terminal phosphorylation controls the stability and function of p27kip1. EMBO J. 2006;25:5159–70. doi: 10.1038/sj.emboj.7601388. PubMed DOI PMC

Kaelin WG, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008;30:393–402. doi: 10.1016/j.molcel.2008.04.009. PubMed DOI

Jokilehto T, Jaakkola PM. The role of HIF prolyl hydroxylases in tumour growth. J Cell Mol Med. 2010;14:758–70. doi: 10.1111/j.1582-4934.2010.01030.x. PubMed DOI PMC

Rantanen K, Pursiheimo J, Högel H, Himanen V, Metzen E, Jaakkola PM. Prolyl hydroxylase PHD3 activates oxygen-dependent protein aggregation. Mol Biol Cell. 2008;19:2231–40. doi: 10.1091/mbc.E07-11-1124. PubMed DOI PMC

Högel H, Rantanen K, Jokilehto T, Grenman R, Jaakkola PM. Prolyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells. PLoS One. 2011;6:e27112. doi: 10.1371/journal.pone.0027112. PubMed DOI PMC

Liu Y, Huo Z, Yan B, Lin X, Zhou ZN, Liang X, Zhu W, Liang D, Li L, Zhao H, et al. Prolyl hydroxylase 3 interacts with Bcl-2 to regulate doxorubicin-induced apoptosis in H9c2 cells. Biochem Biophys Res Commun. 2010;401:231–7. doi: 10.1016/j.bbrc.2010.09.037. PubMed DOI

Lee S, Nakamura E, Yang H, Wei W, Linggi MS, Sajan MP, Farese RV, Freeman RS, Carter BD, Kaelin WG, Schlisio S. Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell. 2005;8:155–67. doi: 10.1016/j.ccr.2005.06.015. PubMed DOI

D’Angelo G, Duplan E, Boyer N, Vigne P, Frelin C. Hypoxia up-regulates prolyl hydroxylase activity: a feedback mechanism that limits HIF-1 responses during reoxygenation. J Biol Chem. 2003;278:38183–7. doi: 10.1074/jbc.M302244200. PubMed DOI

del Peso L, Castellanos MC, Temes E, Martin-Puig S, Cuevas Y, Olmos G, Landazuri MO. The von Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen. J Biol Chem. 2003;278:48690–5. doi: 10.1074/jbc.M308862200. PubMed DOI

Marxsen JH, Stengel P, Doege K, Heikkinen P, Jokilehto T, Wagner T, Jelkmann W, Jaakkola P, Metzen E. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. Biochem J. 2004;381:761–7. doi: 10.1042/BJ20040620. PubMed DOI PMC

Aprelikova O, Chandramouli GV, Wood M, Vasselli JR, Riss J, Maranchie JK, Linehan WM, Barrett JC. Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors. J Cell Biochem. 2004;92:491–501. doi: 10.1002/jcb.20067. PubMed DOI

Rantanen K, Pursiheimo JP, Högel H, Miikkulainen P, Sundström J, Jaakkola PM. p62/SQSTM1 regulates hypoxia response by attenuating PHD3 activity through aggregate sequestration and enhanced degradation. J Cell Sci. 2013;126(Pt 5):1144–54. doi: 10.1242/jcs.115667. PubMed DOI

Ginouves A, Ilc K, Macias N, Pouyssegur J, Berra E. PHDs overactivation during chronic hypoxia “desensitizes” HIFalpha and protects cells from necrosis. Proc Natl Acad Sci U S A. 2008;105:4745–50. doi: 10.1073/pnas.0705680105. PubMed DOI PMC

Stiehl DP, Wirthner R, Köditz J, Spielmann P, Camenisch G, Wenger RH. Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system. J Biol Chem. 2006;281:23482–91. doi: 10.1074/jbc.M601719200. PubMed DOI

Jaakkola PM, Rantanen K. The regulation, localization, and functions of oxygen-sensing prolyl hydroxylase PHD3. Biol Chem. 2013;394:449–57. doi: 10.1515/hsz-2012-0330. PubMed DOI

Moser SC, Bensaddek D, Ortmann B, Maure JF, Mudie S, Blow JJ, Lamond AI, Swedlow JR, Rocha S. PHD1 links cell-cycle progression to oxygen sensing through hydroxylation of the centrosomal protein Cep192. Dev Cell. 2013;26:381–92. doi: 10.1016/j.devcel.2013.06.014. PubMed DOI PMC

Berra E, Benizri E, Ginouves A, Volmat V, Roux D, Pouyssegur J. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1[alpha] in normoxia. EMBO J. 2003;22:4082–90. doi: 10.1093/emboj/cdg392. PubMed DOI PMC

Pursiheimo JP, Rantanen K, Heikkinen PT, Johansen T, Jaakkola PM. Hypoxia-activated autophagy accelerates degradation of SQSTM1/p62. Oncogene. 2009;28:334–44. doi: 10.1038/onc.2008.392. PubMed DOI

Gordan J, Thompson C, Simon M. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell. 2007;12:108–13. doi: 10.1016/j.ccr.2007.07.006. PubMed DOI PMC

Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, Huang LE. HIF-1α induces cell cycle arrest by functionally counteracting Myc. EMBO J. 2004;23:1949–56. doi: 10.1038/sj.emboj.7600196. PubMed DOI PMC

Mack FA, Patel JH, Biju MP, Haase VH, Simon MC. Decreased growth of Vhl-/- fibrosarcomas isassociated with elevated levels of cyclin kinase inhibitors p21 and p27. Mol Cell Biol. 2005; 25:4565-78. PubMed PMC

Xue J, Li X, Jiao S, Wei Y, Wu G, Fang J. Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity. Gastroenterology. 2010;138:606–15. doi: 10.1053/j.gastro.2009.09.049. PubMed DOI

Su Y, Loos M, Giese N, Hines OJ, Diebold I, Görlach A, Metzen E, Pastorekova S, Friess H, Büchler P. PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancer. Br J Cancer. 2010;103:1571–9. doi: 10.1038/sj.bjc.6605936. PubMed DOI PMC

Taniguchi CM, Finger EC, Krieg AJ, Wu C, Diep AN, LaGory EL, Wei K, McGinnis LM, Yuan J, Kuo CJ, Giaccia AJ. Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes. Nat Med. 2013;19:1325–30. doi: 10.1038/nm.3294. PubMed DOI PMC

Guan X, Du L, Chen L, Chen Y, Wang J. Variation of gene expression profile linked to p27 (Kip1) Ser(10) phosphorylation status in MCF-7 cell line. Biomed Pharmacother. 2011;65:537–41. doi: 10.1016/j.biopha.2010.12.003. PubMed DOI

Carmeliet P, Dor Y, Herbert J-M, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, et al. Role of HIF-1[alpha] in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 1998;394:485–90. doi: 10.1038/28867. PubMed DOI

Krtolica A, Krucher NA, Ludlow JW. Molecular analysis of selected cell cycle regulatory proteins during aerobic and hypoxic maintenance of human ovarian carcinoma cells. Br J Cancer. 1999;80:1875–83. doi: 10.1038/sj.bjc.6690615. PubMed DOI PMC

Graff P, Amellem O, Seim J, Stokke T, Pettersen EO. The role of p27 in controlling the oxygen-dependent checkpoint of mammalian cells in late G1. Anticancer Res. 2005;25:2259–67. PubMed

Krucher NA, Krtolica A, Lincoln J, Khan SA, Rodriguez-Rodriguez L, Ludlow JW. Mitogenic activity of steroidogenesis-inducing protein (SIP) during hypoxic stress of human ovarian carcinoma cells. Cancer Lett. 1998;133:205–14. doi: 10.1016/S0304-3835(98)00234-1. PubMed DOI

Box AH, Demetrick DJ. Cell cycle kinase inhibitor expression and hypoxia-induced cell cycle arrest in human cancer cell lines. Carcinogenesis. 2004;25:2325–35. doi: 10.1093/carcin/bgh274. PubMed DOI

Kotake Y, Nakayama K, Ishida N, Nakayama KI. Role of Serine 10 Phosphorylation in p27 Stabilization Revealed by Analysis of p27 Knock-in Mice Harboring a Serine 10 Mutation. J Biol Chem. 2005;280:1095–102. doi: 10.1074/jbc.M406117200. PubMed DOI

Frescas D, Pagano M. Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat Rev Cancer. 2008;8:438–49. doi: 10.1038/nrc2396. PubMed DOI PMC

Guan X, Chen L, Wang J, Geng H, Chu X, Zhang Q, Du L, De W. Mutations of phosphorylation sites Ser10 and Thr187 of p27Kip1 abolish cytoplasmic redistribution but do not abrogate G0/1 phase arrest in the HepG2 cell line. Biochem Biophys Res Commun. 2006;347:601–7. doi: 10.1016/j.bbrc.2006.06.114. PubMed DOI

Théard D, Raspe MA, Kalicharan D, Hoekstra D, van IJzendoorn SC. Formation of E-cadherin/beta-catenin-based adherens junctions in hepatocytes requires serine-10 in p27(Kip1) Mol Biol Cell. 2008;19:1605–13. doi: 10.1091/mbc.E07-07-0661. PubMed DOI PMC

Wang D, He F, Zhang L, Zhang F, Wang Q, Qian X, Pan X, Meng J, Peng C, Shen A, Chen J. The role of p27(Kip1) phosphorylation at serine 10 in the migration of malignant glioma cells in vitro. Neoplasma. 2011;58:65–73. PubMed

Boehm M, Yoshimoto T, Crook MF, Nallamshetty S, True A, Nabel GJ, Nabel EG. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression. EMBO J. 2002;21:3390–401. doi: 10.1093/emboj/cdf343. PubMed DOI PMC

Fujita N, Sato S, Katayama K, Tsuruo T. Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization. J Biol Chem. 2002;277:28706–13. doi: 10.1074/jbc.M203668200. PubMed DOI

Kim J, Jonasch E, Alexander A, Short JD, Cai S, Wen S, Tsavachidou D, Tamboli P, Czerniak BA, Do KA, et al. Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma. Clin Cancer Res. 2009;15:81–90. doi: 10.1158/1078-0432.CCR-08-0170. PubMed DOI PMC

Heikkinen PT, Nummela M, Leivonen SK, Westermarck J, Hill CS, Kähäri VM, Jaakkola PM. Hypoxia-activated Smad3-specific dephosphorylation by PP2A. J Biol Chem. 2010;285:3740–9. doi: 10.1074/jbc.M109.042978. PubMed DOI PMC

Place TL, Domann FE. Prolyl-hydroxylase 3: evolving roles for an ancient signaling protein. vol. 1. pp. 13–27. Hypoxia: Dovepress Journal; 2013. pp. 13–27. PubMed PMC

Lipscomb EA, Sarmiere PD, Crowder RJ, Freeman RS. Expression of the SM-20 gene promotes death in nerve growth factor-dependent sympathetic neurons. J Neurochem. 1999;73:429–32. doi: 10.1046/j.1471-4159.1999.0730429.x. PubMed DOI

Schlisio S, Kenchappa RS, Vredeveld LCW, George RE, Stewart R, Greulich H, Shahriari K, Nguyen NV, Pigny P, Dahia PL, et al. The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Dev. 2008;22(7):884–93. doi: 10.1101/gad.1648608. PubMed DOI PMC

Luo W, Hu H, Chang R, Zhong J, Knabel M, O’Meally R, Cole Robert N, Pandey A, Semenza Gregg L. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell. 2011;145:732–44. doi: 10.1016/j.cell.2011.03.054. PubMed DOI PMC

Chen N, Rinner O, Czernik D, Nytko KJ, Zheng D, Stiehl DP, Zamboni N, Gstaiger M, Frei C. The oxygen sensor PHD3 limits glycolysis under hypoxia via direct binding to pyruvate kinase. Cell Res. 2011;21:983–6. doi: 10.1038/cr.2011.66. PubMed DOI PMC

Fu J, Taubman MB. Prolyl hydroxylase EGLN3 regulates skeletal myoblast differentiation through an NF-κB-dependent pathway. J Biol Chem. 2010;285:8927–35. doi: 10.1074/jbc.M109.078600. PubMed DOI PMC

Fu J, Taubman MB. EGLN3 inhibition of NF-κB is mediated by prolyl hydroxylase-independent inhibition of IκB kinase γ ubiquitination. Mol Cell Biol. 2013;33:3050–61. doi: 10.1128/MCB.00273-13. PubMed DOI PMC